Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients.

Wan S, Lai Y, Myers RE, Li B, Hyslop T, London J, Chatterjee D, Palazzo JP, Burkart AL, Zhang K, Xing J, Yang H.

J Gastrointest Cancer. 2013 Sep;44(3):293-304. doi: 10.1007/s12029-013-9491-9.

2.

Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.

Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K.

Ann Surg Oncol. 2012 Oct;19(11):3422-31. doi: 10.1245/s10434-012-2384-5. Epub 2012 May 11.

PMID:
22576063
3.

Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma.

Kumagai S, Marumo S, Shoji T, Sakuramoto M, Hirai T, Nishimura T, Arima N, Fukui M, Huang CL.

Lung Cancer. 2014 Sep;85(3):457-64. doi: 10.1016/j.lungcan.2014.06.015. Epub 2014 Jun 28.

PMID:
25043641
4.

Elevation of platelet count in patients with colorectal cancer predicts tendency to metastases and poor prognosis.

Lin MS, Huang JX, Zhu J, Shen HZ.

Hepatogastroenterology. 2012 Sep;59(118):1687-90. doi: 10.5754/hge12277.

PMID:
22591645
5.

[Evaluation of thrombocytosis as predictive factor in colorectal cancer].

Baranyai Z, Jósa V, Krzystanek M, Eklund AC, Szász AM, Szállási Z.

Magy Seb. 2013 Dec;66(6):331-7. doi: 10.1556/MaSeb.66.2013.6.5. Hungarian.

PMID:
24333978
6.

Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.

Park IJ, Choi GS, Lim KH, Kang BM, Jun SH.

Ann Surg Oncol. 2009 Nov;16(11):3087-93. doi: 10.1245/s10434-009-0625-z. Epub 2009 Jul 23.

PMID:
19629600
7.

Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.

Tang R, Yeh CY, Wang JY, Changchien CR, Chen JS, Hsieh LL.

Ann Surg Oncol. 2009 Sep;16(9):2516-23. doi: 10.1245/s10434-009-0578-2. Epub 2009 Jun 30.

PMID:
19565285
8.

The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer.

Ozawa T, Ishihara S, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Hata K, Kawai K, Nozawa H, Kazama S, Yamaguchi H, Sunami E, Kitayama J, Watanabe T.

Int J Colorectal Dis. 2015 Sep;30(9):1165-71. doi: 10.1007/s00384-015-2276-9. Epub 2015 Jun 7.

PMID:
26049902
9.

Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.

Riethmüller G, Holz E, Schlimok G, Schmiegel W, Raab R, Höffken K, Gruber R, Funke I, Pichlmaier H, Hirche H, Buggisch P, Witte J, Pichlmayr R.

J Clin Oncol. 1998 May;16(5):1788-94.

PMID:
9586892
10.

Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer.

Mallappa S, Sinha A, Gupta S, Chadwick SJ.

Colorectal Dis. 2013 Mar;15(3):323-8. doi: 10.1111/codi.12008.

PMID:
22958479
11.

The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer.

Baranyai Z, Krzystanek M, Jósa V, Dede K, Agoston E, Szász AM, Sinkó D, Szarvas V, Salamon F, Eklund AC, Szállási Z, Jakab F.

Thromb Haemost. 2014 Mar 3;111(3):483-90. doi: 10.1160/TH13-08-0632. Epub 2013 Nov 28.

PMID:
24285160
12.

Preoperative serum vascular endothelial growth factor-a is a marker for subsequent recurrence in colorectal cancer patients.

Alabi AA, Suppiah A, Madden LA, Monson JR, Greenman J.

Dis Colon Rectum. 2009 May;52(5):993-9. doi: 10.1007/DCR.0b013e31819ed3bc.

PMID:
19502868
13.
14.

Is limited surgery justified in the treatment of T1 colorectal cancer?

Kogler P, Kafka-Ritsch R, Öfner D, Sieb M, Augustin F, Pratschke J, Zitt M.

Surg Endosc. 2013 Mar;27(3):817-25. doi: 10.1007/s00464-012-2518-7. Epub 2012 Dec 12.

PMID:
23232987
15.

Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer.

Sasaki K, Kawai K, Tsuno NH, Sunami E, Kitayama J.

World J Surg. 2012 Jan;36(1):192-200. doi: 10.1007/s00268-011-1329-7.

PMID:
22045447
16.

Does serum CA19-9 play a practical role in the management of patients with colorectal cancer?

Morita S, Nomura T, Fukushima Y, Morimoto T, Hiraoka N, Shibata N.

Dis Colon Rectum. 2004 Feb;47(2):227-32.

PMID:
15043294
17.

Prognostic value of serum neutrophil gelatinase-associated lipocalin in metastatic and nonmetastatic colorectal cancer.

Martí J, Fuster J, Solà AM, Hotter G, Molina R, Pelegrina A, Ferrer J, Deulofeu R, Fondevila C, García-Valdecasas JC.

World J Surg. 2013 May;37(5):1103-9. doi: 10.1007/s00268-013-1930-z.

PMID:
23389669
18.

[Association of preoperative platelet count with the prognosis of patients with colorectal cancer].

Chen LL, Zhang L, Li YL, Li XL, Liu WH, Yan J, Yang YF.

Nan Fang Yi Ke Da Xue Xue Bao. 2016 Apr;36(4):482-7. Chinese.

PMID:
27113174
19.

Factors predicting long-term survival in colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.

Huh JW, Kim CH, Lim SW, Kim HR, Kim YJ.

J Cancer Res Clin Oncol. 2013 Sep;139(9):1449-55. doi: 10.1007/s00432-013-1459-4. Epub 2013 Jun 14.

PMID:
23765330
20.

Elevation of preoperative s-CEA concentration in stage IIA colorectal cancer can also be a high risk factor for stage II patients.

Kim CW, Yoon YS, Park IJ, Lim SB, Yu CS, Kim JC.

Ann Surg Oncol. 2013 Sep;20(9):2914-20. doi: 10.1245/s10434-013-2919-4. Epub 2013 Jun 13.

PMID:
23760586
Items per page

Supplemental Content

Write to the Help Desk